Debbie Abrahams
Main Page: Debbie Abrahams (Labour - Oldham East and Saddleworth)Department Debates - View all Debbie Abrahams's debates with the Department of Health and Social Care
(1 year, 5 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
I beg to move,
That this House has considered the future of cancer care.
Cancer will affect every single one of us here today, and every single person in this country, in some way. Statistically, half of us will get cancer in our lifetime. When that happens, both we and our families should expect the best possible care and support from our health service. This time last year, my family and I were coming to terms with losing my mum to secondary breast cancer that spread to her liver. She passed away in April 2022, only six years after her younger sister passed away with the same diagnosis. Their brother, my uncle, has since bravely fought cancer too, and I am pleased to say—not least because he tells the worst dad jokes known to man—that he is doing well.
My family know all too well what the statistics mean in real life. I would like to think that I am one of the few to have lost their mother at an young age, but that is not true. A member of my team, Bradley, reminded me that his mother, Sharon Langer, would have been 58 today. She died in December 2018 from lung cancer.
Thanks to our health and care services, we have taken great strides in improving cancer survival rates. Over the last 40 years, the survival rate has doubled in this country, and now half of the people diagnosed with cancer in England and Wales survive their disease for 10 years or more. However, the number of cancer cases will only rise in the years ahead. Modelling by Cancer Research UK suggests that cases will rise by around a third, with as many as 506,000 people being diagnosed with cancer between in 2038 and 2040. That is not wholly because of a growing and ageing population, as incidence rates are also due to rise, meaning that individuals will be more likely to be diagnosed with cancer than they are now.
My condolences to the hon. Lady on the loss of her mum, which must have been horrendous. One of my constituents, Jo Taylor, has received an advanced breast cancer diagnosis; hon. Members may have seen her on social media. She is campaigning to make sure that secondary breast cancer, as it is also known, is counted, because currently we only estimate the number of women—and men—with secondary breast cancer. We know that figures drive care. Does the hon. Lady think that that is something the Government will take on board?
I totally agree. Any statistics and data that we can gather will help us to improve services and understand the landscape when it comes to who is affected and when cancer can recur, and it is important that we take all that into account. It is important to have a long-term plan for making our cancer services fit for what is to come. They need to cope with the increased demand, and deliver the world-leading outcomes that patients deserve.
Last year, the Government declared war on cancer. They announced a 10-year plan to ramp up our cancer services and make them the world leader that they ought to be. However, we now know that our plans for cancer care will become part of the five-year major conditions strategy. Although it is clearly important to take a holistic approach to caring for people with life-threatening diseases, there is no killer like cancer. We must ensure that our strategy addresses the key elements of what would be a world-leading cancer care system: research, prevention, diagnosis, treatment and care. I will first discuss one of the most important elements that we need addressed in the strategy: diagnosis.
Finding cancer early and commencing treatment is key to survival rates. For instance, 90% of people diagnosed at the earliest stage of bowel cancer will survive for five years or more, compared with just 10% of those diagnosed at the latest stage. Furthermore, almost everyone diagnosed with breast cancer at the earliest stage can receive treatment and live for five years or more, whereas only three in 10 women diagnosed at the latest stage survive for more than five years. The picture also varies by region. Unfortunately, if someone lives in the west midlands, they are statistically less likely to survive for five years or more after being diagnosed with lung cancer than those across England on average, and all combined mortality rates are significantly higher than average, too. Those stark figures hammer home the need to make sure that we detect cancer and commence treatment at the earliest opportunity.
I welcome the commitment from the Secretary of State for Health and Social Care that the strategy will shift our model towards the early detection and treatment of diseases. I also welcome the ambitious target set to diagnose 75% of cancers early by 2028. I look forward to reviewing how the strategy will address the need for greater capacity in the breast screening programme, ensure that all women at elevated risk of breast cancer are included in the national breast screening programme, and raise the proportion of all cancers that are diagnosed early; at present, just under 60% are.
Of course, it is not enough to detect cancer in its earliest stage. We also have to make sure that people receive treatment promptly, especially after urgent referrals. Much work still needs to be done in that area. Only 54.5% of people starting their treatment after an urgent referral do so within the 62-day target, and around 2,100 people have waited more than 104 days to begin their treatment. In my constituency of West Bromwich East and the wider Sandwell area, there is a mixed picture when it comes to meeting those important targets. It is welcome that our local health service met the two-week target for referring urgent suspected cancer cases to a specialist. However, like much of the rest of the country, other targets, including the 62-day standard, were not met. When I compare those statistics with the survival rates that I mentioned, it is obvious that we have to do more to ensure that people start treatment as early as possible. A critical element of that is ensuring that cancer services are sufficiently well staffed.
It would be remiss of me not to honour the people who work day in, day out, providing care for cancer patients across the country. We have all relied on them to care for us and our loved ones, in sometimes the most desperate circumstances, and to provide comfort for us in our time of need. I put on the record my thanks to the Mary Stevens Hospice in the constituency of my hon. Friend the Member for Stourbridge (Suzanne Webb); it looked after my mum in her last days, and held a last-minute wedding blessing for me and my now husband at my mum’s request.
We need to address the shortfalls in the workforce that are affecting our success in improving cancer outcomes. We have a shortfall of both clinical oncologists and radiologists, who are vital to the effort to diagnose and treat cancer patients in the earliest stages. It is so important to tackle the workforce issues with long-term plans to recruit and train the staff we need to tackle cancer properly. I welcome the Government’s NHS long-term workforce plan, which commits to addressing those and many other issues across the NHS workforce. I ask the Government to ensure that the necessary funding is provided to meet those commitments.
On the major conditions strategy, I hope that the Government will take into account the wealth of views expressed by Cancer Research UK and other key organisations in the cancer community in last year’s call for evidence, and ensure that the strategy lays the groundwork for a longer-term strategy on cancer that also tackles inequalities.